(NEW YORK)Analysts on Friday brushed off Biogen Idec Inc.'s decision to abandon development of an experimental arthritis drug, saying it had not even been included in models for future reven...READ MORE
(CAMBRIDGE, Mass.)Biotech drug maker Biogen Idec said Thursday it has abandoned development of an experimental arthritis drug after it missed several goals in a mid-stage study.READ MORE